Violich Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $551K | Hold |
1,100
| – | – | 0.06% | 81 |
|
|
2026
Q1 | $541K | Hold |
1,100
| – | – | 0.06% | 81 |
|
|
2025
Q4 | $637K | Buy |
1,100
+50
| +5% | +$28.3K | 0.07% | 72 |
|
|
2025
Q3 | $509K | Buy |
1,050
+39
| +4% | +$18.2K | 0.06% | 78 |
|
|
2025
Q2 | $410K | Sell |
1,011
-141
| -12% | -$59K | 0.06% | 79 |
|
|
2025
Q1 | $573K | Hold |
1,152
| – | – | 0.08% | 72 |
|
|
2024
Q4 | $599K | Buy |
1,152
+139
| +14% | +$76.4K | 0.08% | 70 |
|
|
2024
Q3 | $627K | Hold |
1,013
| – | – | 0.08% | 73 |
|
|
2024
Q2 | $560K | Sell |
1,013
-500
| -33% | -$286K | 0.08% | 76 |
|
|
2024
Q1 | $879K | Buy |
1,513
+1,013
| +203% | +$568K | 0.13% | 66 |
|
|
2023
Q4 | $265K | Hold |
500
| – | – | 0.04% | 92 |
|
|
2023
Q3 | $253K | Sell |
500
-10
| -2% | -$5.33K | 0.04% | 93 |
|
|
2023
Q2 | $266K | Hold |
510
| – | – | 0.04% | 100 |
|
|
2023
Q1 | $294K | Sell |
510
-10
| -2% | -$5.64K | 0.05% | 91 |
|
|
2022
Q4 | $286K | Hold |
520
| – | – | 0.05% | 91 |
|
|
2022
Q3 | $264K | Hold |
520
| – | – | 0.05% | 92 |
|
|
2022
Q2 | $283K | Sell |
520
-30
| -5% | -$16.5K | 0.05% | 96 |
|
|
2022
Q1 | $325K | Hold |
550
| – | – | 0.05% | 94 |
|
|
2021
Q4 | $367K | Hold |
550
| – | – | 0.05% | 88 |
|
|
2021
Q3 | $314K | Hold |
550
| – | – | 0.05% | 97 |
|
|
2021
Q2 | $277K | Hold |
550
| – | – | 0.05% | 97 |
|
|
2021
Q1 | $251K | Hold |
550
| – | – | 0.05% | 97 |
|
|
2020
Q4 | $256K | Buy |
+550
| New | +$258K | 0.05% | 92 |
|
|
2020
Q3 | – | Sell |
-1,300
| Closed | -$471K | – | 111 |
|
|
2020
Q2 | $471K | Sell |
1,300
-25
| -2% | -$8.38K | 0.1% | 76 |
|
|
2020
Q1 | $376K | Buy |
1,325
+50
| +4% | +$15.8K | 0.1% | 76 |
|
|
2019
Q4 | $414K | Hold |
1,275
| – | – | 0.09% | 83 |
|
|
2019
Q3 | $371K | Hold |
1,275
| – | – | 0.09% | 85 |
|
|
2019
Q2 | $374K | Hold |
1,275
| – | – | 0.09% | 84 |
|
|
2019
Q1 | $349K | Hold |
1,275
| – | – | 0.09% | 87 |
|
|
2018
Q4 | $285K | Buy |
1,275
+20
| +2% | +$4.69K | 0.08% | 89 |
|
|
2018
Q3 | $306K | Hold |
1,255
| – | – | 0.07% | 94 |
|
|
2018
Q2 | $260K | Sell |
1,255
-30
| -2% | -$6.37K | 0.07% | 101 |
|
|
2018
Q1 | $265K | Hold |
1,285
| – | – | 0.07% | 94 |
|
|
2017
Q4 | $244K | Hold |
1,285
| – | – | 0.06% | 102 |
|
|
2017
Q3 | $243K | Sell |
1,285
-10
| -0.8% | -$1.81K | 0.07% | 99 |
|
|
2017
Q2 | $226K | Buy |
+1,295
| New | +$218K | 0.07% | 95 |
|
|
2017
Q1 | – | Sell |
-1,295
| Closed | -$200K | – | 115 |
|
|
2016
Q4 | $200K | Hold |
1,295
| – | – | 0.06% | 103 |
|
|
2016
Q3 | $206K | Buy |
+1,295
| New | +$200K | 0.07% | 95 |
|
Other funds holding TMO
RG
ECSS
LT
Violich Capital Management's TMO Position: Q2 2026 in Review
Violich Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,100 shares worth $551K. The position accounts for 0.06% of the portfolio, ranked #81.
Violich Capital Management first reported a position in TMO in Q3 2016 and has held it in 38 quarters since. The position peaked at $879K in Q1 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Violich Capital Management held 1,100 shares of Thermo Fisher Scientific worth $551K as of Q2 2026.
- Violich Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.06% of Violich Capital Management's portfolio in Q2 2026, its #81 holding.
- Violich Capital Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 38 quarters since.
- Violich Capital Management's Thermo Fisher Scientific position peaked at $879K in Q1 2024.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.